PR Newswire

Cision is a leading global provider of earned media software. Cision PR Newswire empowers communicators to identify influencers, craft campaigns and attribute value from the broadest spectrum of media sources, allowing them to create meaningful stories and measure the impact.
Results: 20161-20172 of 26058

AvenCell Announces First Patient Dosed in a Phase IA Study with lead product candidate AVC-201, a Novel Allogeneic CD123-Directed Switchable CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia and other CD123 Hematological Malignancies
